Oligo Synthesis | Gene Synthesis | RNA Synthesis | Recombinant Antibody Expression
Tsingke is a pioneering nucleic acid manufacturer distinguished by its innovative R&D capabilities in oligo synthesizers, raw materials, and automated production systems. Founded in 2004, Tsingke has grown into “The Great Gene Factory,” serving over 200,000 customers worldwide. With 70,000 m² of operating area, 21 branches, and 6 production bases, the company holds more than 200 patents and is ISO9001 & ISO13485 certified.
Our state-of-the-art integrated platforms empower us to deliver cutting-edge synthetic genomics products, unlocking the potential of genetic research. As of December 2025, articles citing Tsingke’s products have achieved a cumulative Impact Factor exceeding 150,000, with over 22,700 citations. Tsingke’s mission – Biotech for a better world – drives our leadership in DNA/RNA synthesis, gene synthesis, protein & antibody services, and bioreagents, supporting molecular diagnostics, vaccine development, gene editing, gene therapy, agricultural biotech, and drug discovery.
Custom Oligo Synthesis – Any scale, modification, purification, and QC package
Gene Synthesis for challenging sequences – Toxic genes, high/low GC, repeats, long fragments (up to 200 kb)
Custom Protein & Antibody Services – From gene to purified protein/antibody, including HEK293/CHO/Ecoli/Yeast systems
We gladly support you by keeping you updated on our latest products and developments
